Product Information
CLARINEX 5 MG TABLET is a brand product labeled by Organon LLC, priced at $8.8476 per EA under NDC 78206018801. Its NADAC has been published 103 times since Jul 17, 2024.
FDA first approved this application on Dec 21, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Organon LLCNDC
78206018801
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DESLORATADINEApproval Type
New Drug (NDA)
FDA Application
NDA021165FDA Approved
12/21/2001
TE Code
AB
On Market Since
8/23/2022
Pharmacological Classes
Price Statistics
The NADAC for CLARINEX 5 MG TABLET has been published 103 times since Jul 17, 2024, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8476 per EA |
|---|---|
| All-time high | $8.8476 (Sep 30, 2026) |
| All-time low | $8.0580 (Sep 18, 2024) |
| 52-week high | $8.8476 |
| 52-week low | $8.4610 |
| Median price | $8.4610 |
| Average price | $8.4911 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 103 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desloratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARINEX 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLARINEX 5 MG TABLET, manufactured by Organon LLC, is $8.8476 per EA (NDC 78206018801), effective Sep 30, 2026.
How has the price of CLARINEX 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLARINEX 5 MG TABLET has risen 9.8%. It has been tracked across 103 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CLARINEX 5 MG TABLET?
Since Jul 17, 2024, the NADAC for CLARINEX 5 MG TABLET has ranged from a low of $8.0580 (Sep 18, 2024) to a high of $8.8476 (Sep 30, 2026), with a median of $8.4610 per EA.
Are there cheaper alternatives to CLARINEX 5 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DESLORATADINE 5 MG TABLET, is $0.2553 per EA — about 97% below CLARINEX 5 MG TABLET.
Who manufactures CLARINEX 5 MG TABLET?
CLARINEX 5 MG TABLET (NDC 78206018801) is labeled by Organon LLC, and CMS classifies it as a brand product.